Watch ProMIS Neurosciences CEO, Neil Warma’s, recent conversation with Precision AQ during JPM 2025 to learn more about the significant progress we have made with our lead program, PMN310, and the anticipated milestones for 2025 and beyond!

Continue

Posters & Publications

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

Poster

Phase 1a Single Ascending Dose Study of PMN310, a monoclonal antibody directed against toxic Aβ oligomers

See Poster
Presentation

Distinguishing between Ab-directed antibodies: Ability of PMN310 to target toxic oligomers despite competing species

View Presentation
Poster

Novel approach to optimization of Alzheimer’s vaccine configuration for maximal targeting of toxic amyloid-beta oligomers

See Poster
Manuscript

Relationship between therapeutic activity and preferential targeting of toxic soluble aggregates by amyloid-beta-directed antibodies

View Manuscript
Publication

Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration

View Publication
Poster

Selective targeting and protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease

See Poster
Poster

Rational design of a vaccine for Alzheimer’s disease using a computationallyderived conformational epitope to selectively target toxic amyloid-beta oligomers

See Poster
Presentation

AAN 2023 Presentation – Rational design of a vaccine for Alzheimer’s disease using computationally-derived conformational B cell epitopes to selectively target toxic amyloid-beta oligomers

View Presentation
Poster

AAN 2023 Poster – RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP

See Poster
Poster

AAN 2023 Poster – Protection against toxic amyloid-beta oligomers by PMN310 in Alzheimer’s disease

See Poster
Poster

AD/PD 2023 Poster

See Poster
Manuscript

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein

View Manuscript